• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Iron Deficiency in Blood Donors

June 27, 2014

Based on data from the CDC, 8-19% of women 20-49 years of age have iron deficiency in the United States.  In a recent commentary in TRANSFUSION, Sayers and Centilli discuss the AABB’s recommendations from Bulletin #12-03, “Strategies to Monitor, Limit or Prevent Iron Deficiency in Blood Donors,” which includes increasing the donation interval, measuring donor ferritin, and iron replacement.

Since the bulletin did not give specifics on increasing the donation interval, Sayers and Centilli examined donation records from 78,489 female donors who were deferred because of hemoglobin (Hb) levels less than the cutoff of 12.5 g/dL.  About 60% of the deferred donors returned, and these donors were more likely to have a successful donation the longer they waited to return and the closer their deferral Hb was to the cutoff.  They also found, however, that over a quarter of those with original levels just below the cutoff (12.2-12.4g/dL) were deferred again, even though they returned between 21 and 24 weeks.  These finding support the bulletin’s recommendation of also measuring iron stores and iron replacement.

References

1. Sayers M, Centilli J. Concerning iron balance in blood donors. Transfusion 2014.
2. Triulzi DJ, Shoos KL. Strategies to monitor, limit, or prevent iron deficiency in blood donors. AABB 2012, Association Bulletin #12-03. [cited 2014 Mar 6]. Available from: http://www.aabb.org/resources/publications/bulletins/Pages/ab12-03.aspx.

Filed Under

  • Blood Donation
  • News

Recommended

  • Recombinant ADAMTS13 Treatment for Congenital Thrombotic Thrombocytopenic Purpura

  • Transplant of Tissue-Engineered Esophagus Seeded with Stem Cells

  • COVID-19 Convalescent Plasma Improves Outcomes for Cancer Patients

Show Comments

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • Babesia Infection Reduces Red Cell Deformability

  • New Erythropoietin Gene Variants Linked to Hereditary Erythrocytosis

  • Multifaceted Threats to the Blood Supply from Climate Change

  • Distinct Roles for Differently Aged Platelets

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley